Tilray Brands, Inc.
Every calculator, already run for TLRY
Open the full toolkit →You have the numbers on TLRY. Get the argument.
A written report on which of these readings actually decide the outcome for Tilray Brands, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
3 analysts covering TLRYAnalyst Price Target Disagreement for Tilray Brands, Inc.
Wall Street's bull case implies +302% from the current price; the bear case implies +0%. A 301% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for TLRY
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web…
TLRY — frequently asked
Is TLRY a buy right now?
Wall Street's consensus rating on Tilray Brands, Inc. is Buy across 3 analysts, with a mean price target of $7.34 (+74% vs. the current $4.23). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is TLRY's next earnings date?
Tilray Brands, Inc. is next scheduled to report earnings around Oct 8, 2026. A full TLRY research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Tilray Brands, Inc.?
Analysts covering Tilray Brands, Inc. (TLRY) range from a bear-case target of $4.25 to a bull-case high of $17.00, with a mean consensus target of $7.34 across 8 analysts. The spread of $12.75 (301% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Tilray Brands, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Tilray Brands, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full TLRY research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Tilray Brands, Inc., in minutes. 3 free reports included with every account — no credit card required.